Science Explorer Back to mapMap
Discussion
Researcher · Gilead Sciences (United States) · United States

Bing Lu

Bing Lu publishes mostly in Infectious Diseases, Epidemiology and Virology, on topics such as HIV Research and Treatment, COVID-19 Clinical Research Studies and HIV/AIDS drug development and treatment.

ORCID 0000-0002-1195-2897 OpenAlex
World rank
#1,872,897
of 7,710,434 ranked researchers
Rank in United States
#573,083
of 1,627,098
Works
17
Citations
604
Citations per work
35.5
h-index
12
i10-index 12Top 53% in Infectious Diseases
Bing Lu

What does Bing Lu research?

Bing Lu's work is mostly in Medicine (57%), Immunology and Microbiology (10%), Mathematics (4%).

Health Sciences: 10 works · 56.9% of their workMedicine: 10 works · 56.9% of their workInfectious Diseases: 7 works · 39.2% of their workEpidemiology: 2 works · 11.8% of their workNeurology: 1 works · 5.9% of their workEverything else: 4 works · 25.5% of their workLife Sciences: 2 works · 9.8% of their workImmunology and Microbiology: 2 works · 9.8% of their workVirology: 2 works · 9.8% of their workPhysical Sciences: 1 works · 3.9% of their workMathematics: 1 works · 3.9% of their workModeling and Simulation: 1 works · 3.9% of their workSocial Sciences: 1 works · 3.9% of their workSocial Sciences: 1 works · 3.9% of their workHealth: 1 works · 3.9% of their workTHEIR WORKBing Lu17works
Life Sciences10%Physical Sciences4%Health Sciences57%Social Sciences4%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1056.9%
  2. Everything else425.5%
    1. Immunology and Microbiology29.8%
    1. Mathematics13.9%
    1. Social Sciences13.9%
  1. 1Infectious Diseases39% of their works
  2. 2Epidemiology12% of their works
  3. 3Virology10% of their works
  4. 4Neurology6% of their works
  5. 5Modeling and Simulation4% of their works
  6. 6Health4% of their works

Research topics

Which keywords describe Bing Lu's research?

The keywords of their largest research topics: Antiretroviral Therapy, Pandemic, SARS-CoV-2, Immune Response, ACE2 Receptor, Antibodies, Epidemiology and Vaccine.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 25 words, with their numbers
  1. Antiretroviral Therapy133 topics
  2. Pandemic113 topics
  3. SARS-CoV-2113 topics
  4. Immune Response102 topics
  5. ACE2 Receptor82 topics
  6. Antibodies82 topics
  7. Epidemiology82 topics
  8. Vaccine82 topics
  9. Viral Load62 topics
  10. AIDS51 topic
  11. Clinical Characteristics51 topic
  12. Drug Resistance51 topic
  13. HIV51 topic
  14. HIV Infection51 topic
  15. Thrombosis51 topic
  16. COVID-1931 topic
  17. Coronavirus31 topic
  18. Diagnostics31 topic
  19. HIV Transmission31 topic
  20. Influenza31 topic
  21. Preexposure Prophylaxis31 topic
  22. Virus31 topic
  23. spike protein31 topic
  24. Innate Memory21 topic
  25. Trained Immunity21 topic

Where does Bing Lu work?

Bing Lu's main affiliation in the publication record is Gilead Sciences (United States), United States.

How many publications and citations does Bing Lu have?

OpenAlex counts 17 works and 604 citations for Bing Lu, an h-index of 12, ranking #1,872,897 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Bing Lu

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Bing Lu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.